Unitedhealth Group Incorporated Stock Buy Hold or Sell Recommendation

UNH Stock  USD 483.70  5.33  1.09%   
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding UnitedHealth Group Incorporated is 'Cautious Hold'. Macroaxis provides UnitedHealth Group buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding UNH positions. The advice algorithm takes into account all of UnitedHealth Group's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting UnitedHealth Group's buy or sell advice are summarized below:
Real Value
520.53
Target Price
558.19
Hype Value
483.41
Market Value
483.7
Naive Value
507.64
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell UnitedHealth Group Incorporated given historical horizon and risk tolerance towards UnitedHealth Group. When Macroaxis issues a 'buy' or 'sell' recommendation for UnitedHealth Group Incorporated, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out UnitedHealth Group Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
In addition, we conduct extensive research on individual companies such as UnitedHealth and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards UnitedHealth Group Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

Execute UnitedHealth Group Buy or Sell Advice

The UnitedHealth recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on UnitedHealth Group Incorporated. Macroaxis does not own or have any residual interests in UnitedHealth Group Incorporated or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute UnitedHealth Group's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell UnitedHealth GroupBuy UnitedHealth Group
Cautious Hold

Market Performance

Very WeakDetails

Volatility

Very steadyDetails

Hype Condition

Low keyDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Slowly supersedes the marketDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

HealthyDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon UnitedHealth Group Incorporated has a Mean Deviation of 1.04, Semi Deviation of 1.67, Standard Deviation of 1.56, Variance of 2.44, Downside Variance of 2.91 and Semi Variance of 2.81
Macroaxis provides recommendation on UnitedHealth Group to complement and cross-verify current analyst consensus on UnitedHealth Group Incorporated. Our trade recommendation engine determines the firm's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure UnitedHealth Group is not overpriced, please validate all UnitedHealth Group fundamentals, including its current ratio, total asset, and the relationship between the net income and price to earnings to growth . Given that UnitedHealth Group has a price to earning of 26.34 X, we advise you to double-check UnitedHealth Group Incorporated market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your current risk tolerance and investing horizon.

UnitedHealth Group Trading Alerts and Improvement Suggestions

UnitedHealth Group generated a negative expected return over the last 90 days
The company has 67.44 B in debt with debt to equity (D/E) ratio of 0.59, which is OK given its current industry classification. UnitedHealth Group has a current ratio of 0.76, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Debt can assist UnitedHealth Group until it has trouble settling it off, either with new capital or with free cash flow. So, UnitedHealth Group's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like UnitedHealth Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for UnitedHealth to invest in growth at high rates of return. When we think about UnitedHealth Group's use of debt, we should always consider it together with cash and equity.
Over 90.0% of UnitedHealth Group outstanding shares are owned by institutional investors
On 19th of March 2024 UnitedHealth Group paid $ 1.88 per share dividend to its current shareholders
Latest headline from finance.yahoo.com: UnitedHealth hackers took advantage of Citrix vulnerabilty to break in, CEO says

UnitedHealth Group Returns Distribution Density

The distribution of UnitedHealth Group's historical returns is an attempt to chart the uncertainty of UnitedHealth Group's future price movements. The chart of the probability distribution of UnitedHealth Group daily returns describes the distribution of returns around its average expected value. We use UnitedHealth Group Incorporated price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of UnitedHealth Group returns is essential to provide solid investment advice for UnitedHealth Group.
Mean Return
0
Value At Risk
-2.1
Potential Upside
2.15
Standard Deviation
1.56
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of UnitedHealth Group historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

UnitedHealth Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as UnitedHealth Group is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading UnitedHealth Group Incorporated backward and forwards among themselves. UnitedHealth Group's institutional investor refers to the entity that pools money to purchase UnitedHealth Group's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Alliancebernstein L.p.2023-12-31
12 M
Capital Research & Mgmt Co - Division 32023-12-31
11.9 M
Goldman Sachs Group Inc2023-12-31
11.2 M
Bank Of America Corp2023-12-31
11.1 M
Norges Bank2023-12-31
11 M
Royal Bank Of Canada2023-12-31
10 M
Northern Trust Corp2023-12-31
9.6 M
Legal & General Group Plc2023-12-31
8.5 M
Bank Of New York Mellon Corp2023-12-31
8.3 M
Vanguard Group Inc2023-12-31
83.9 M
Blackrock Inc2023-12-31
72.4 M
Note, although UnitedHealth Group's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

UnitedHealth Group Cash Flow Accounts

201920202021202220232024 (projected)
Change In Cash119M5.9B4.5B2.0B2.1B2.2B
Free Cash Flow16.4B20.1B19.9B23.4B25.7B27.0B
Depreciation2.7B2.9B3.1B3.4B4.0B4.2B
Other Non Cash Items294M(52M)(944M)673M258M245.1M
Capital Expenditures2.1B2.1B2.5B2.8B3.4B3.6B
Net Income14.2B15.8B17.7B20.6B22.4B23.5B
End Period Cash Flow11.0B16.9B21.4B23.4B25.4B26.7B
Dividends Paid3.9B4.6B5.3B6.0B6.8B7.1B
Change To Inventory(1.6B)(2.2B)(1.0B)1.0B934.2M599.3M
Investments(2.5B)(2.8B)(1.8B)(28.5B)(15.6B)(14.8B)
Change Receivables162M(688M)1B(2.5B)(2.3B)(2.2B)
Net Borrowings4.0B2.6B2.5B12.5B14.4B15.1B
Change To Netincome821M619M433M(79M)(90.9M)(86.3M)

UnitedHealth Group Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to UnitedHealth Group or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that UnitedHealth Group's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a UnitedHealth stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
-0.02
β
Beta against NYSE Composite0.28
σ
Overall volatility
1.58
Ir
Information ratio -0.04

UnitedHealth Group Volatility Alert

UnitedHealth Group Incorporated has relatively low volatility with skewness of -0.48 and kurtosis of 4.95. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure UnitedHealth Group's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact UnitedHealth Group's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

UnitedHealth Group Implied Volatility

UnitedHealth Group's implied volatility exposes the market's sentiment of UnitedHealth Group Incorporated stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if UnitedHealth Group's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that UnitedHealth Group stock will not fluctuate a lot when UnitedHealth Group's options are near their expiration.

UnitedHealth Group Fundamentals Vs Peers

Comparing UnitedHealth Group's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze UnitedHealth Group's direct or indirect competition across all of the common fundamentals between UnitedHealth Group and the related equities. This way, we can detect undervalued stocks with similar characteristics as UnitedHealth Group or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of UnitedHealth Group's fundamental indicators could also be used in its relative valuation, which is a method of valuing UnitedHealth Group by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare UnitedHealth Group to competition
FundamentalsUnitedHealth GroupPeer Average
Return On Equity0.17-0.31
Return On Asset0.0709-0.14
Profit Margin0.04 %(1.27) %
Operating Margin0.08 %(5.51) %
Current Valuation496.36 B16.62 B
Shares Outstanding920.08 M571.82 M
Shares Owned By Insiders0.22 %10.09 %
Shares Owned By Institutions90.24 %39.21 %
Number Of Shares Shorted7.89 M4.71 M
Price To Earning26.34 X28.72 X
Price To Book4.56 X9.51 X
Price To Sales1.09 X11.42 X
Revenue371.62 B9.43 B
Gross Profit79.62 B27.38 B
EBITDA36.33 B3.9 B
Net Income22.38 B570.98 M
Cash And Equivalents27.91 B2.7 B
Cash Per Share45.51 X5.01 X
Total Debt67.44 B5.32 B
Debt To Equity0.59 %48.70 %
Current Ratio0.78 X2.16 X
Book Value Per Share100.18 X1.93 K
Cash Flow From Operations29.07 B971.22 M
Short Ratio1.77 X4.00 X
Earnings Per Share16.38 X3.12 X
Price To Earnings To Growth1.24 X4.89 X
Target Price566.61
Number Of Employees440 K18.84 K
Beta0.56-0.15
Market Capitalization449.95 B19.03 B
Total Asset278.42 B29.47 B
Retained Earnings95.77 B9.33 B
Working Capital(20.62 B)1.48 B
Note: Payment of 372 shares by Andrew Witty of UnitedHealth Group subject to Rule 16b-3 [view details]

UnitedHealth Group Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as UnitedHealth . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About UnitedHealth Group Buy or Sell Advice

When is the right time to buy or sell UnitedHealth Group Incorporated? Buying financial instruments such as UnitedHealth Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2021 2022 2023 2024 (projected)
Total Current Liabilities78.3B89.2B99.1B104.0B
Total Assets212.2B245.7B278.4B292.3B

Use Investing Ideas to Build Portfolios

In addition to having UnitedHealth Group in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Market Neutral Funds Thematic Idea Now

Market Neutral Funds
Market Neutral Funds Theme
Funds or Etfs that invest in both long and short positions of different entities to enhance returns from broad market movements over time. The Market Neutral Funds theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Market Neutral Funds Theme or any other thematic opportunities.
View All  Next Launch
When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:
Check out UnitedHealth Group Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Complementary Tools for UnitedHealth Stock analysis

When running UnitedHealth Group's price analysis, check to measure UnitedHealth Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UnitedHealth Group is operating at the current time. Most of UnitedHealth Group's value examination focuses on studying past and present price action to predict the probability of UnitedHealth Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UnitedHealth Group's price. Additionally, you may evaluate how the addition of UnitedHealth Group to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Is UnitedHealth Group's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.16
Dividend Share
7.52
Earnings Share
16.38
Revenue Per Share
411.257
Quarterly Revenue Growth
0.086
The market value of UnitedHealth Group is measured differently than its book value, which is the value of UnitedHealth that is recorded on the company's balance sheet. Investors also form their own opinion of UnitedHealth Group's value that differs from its market value or its book value, called intrinsic value, which is UnitedHealth Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UnitedHealth Group's market value can be influenced by many factors that don't directly affect UnitedHealth Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.